U.S. FDA says Evusheld may not protect against Omicron subvariant XBB.1.5 (Reuters) – The U.S. Food and Drug Administration said on Friday it does not expect AstraZeneca’s COVID-19 antibody cocktail Evusheld to provide protection against the Omicron subvariant XBB.1.5. The subvariant has been…
Governor Hochul says omicron variant ‘it’s coming’ to New York, announces authority to cut elective surgeries as staffing shortages continue